Since VprBP-mediated H2AT120p displays a sharp reduction in G361 and MeWo melanoma cells treated with VprBP inhibitor B32B3 (Figure 2C and Figure S3C), we wondered whether the growth of melanoma cells is also suppressed by such B32B3 treatments. Here, DCAF1 is linked to melanoma.